THYROID EYE DISEASE
Clinical trials for THYROID EYE DISEASE explained in plain language.
Never miss a new study
Get alerted when new THYROID EYE DISEASE trials appear
Sign up with your email to follow new studies for THYROID EYE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Thyroid eye disease drug trial halted after disappointing results
Disease control TerminatedThis study tested a drug called efgartigimod for adults with active, moderate-to-severe thyroid eye disease, a condition that causes bulging eyes and vision problems. About 102 people were enrolled to receive either the drug or a placebo. The trial was stopped early because early…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
Hope for thyroid eye disease: new drug shows promise in Long-Term study
Disease control TerminatedThis study looks at how well batoclimab works over time for people with thyroid eye disease, a condition that causes eye bulging and discomfort. It includes about 109 adults who finished earlier studies. Some participants will receive batoclimab, while others will be observed to …
Matched conditions: THYROID EYE DISEASE
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
Thyroid eye disease drug trial halted early – no safety issues
Disease control TerminatedThis study tested a drug called efgartigimod for adults with active, moderate-to-severe thyroid eye disease. Participants received either the drug or a placebo by injection. The trial was stopped early because early results showed the drug was unlikely to work as hoped, but no sa…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 26, 2026 11:59 UTC
-
Promising eye disease drug trial halted early
Disease control TerminatedThis study tested a drug called secukinumab for people with active, moderate-to-severe thyroid eye disease, a condition that causes eye bulging and discomfort. The trial aimed to see if the drug could reduce eye swelling and bulging over 16 weeks. However, the study was stopped e…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New pill for thyroid eye disease shows early promise
Symptom relief TerminatedThis early study tested a drug called K9 in healthy volunteers and in people with thyroid eye disease (TED). The goal was to check safety and see if it helps with symptoms like dry eyes. Up to 10 patients took K9 twice daily for 24 weeks. The study was stopped early, so results a…
Matched conditions: THYROID EYE DISEASE
Phase: PHASE1 • Sponsor: Peter Timoney • Aim: Symptom relief
Last updated May 26, 2026 12:02 UTC